Martinez de la Torre, Adrian
Clausen, Andreas Bech
Burden, Andrea M.
Weiler, Stefan https://orcid.org/0000-0003-1087-7597
Funding for this research was provided by:
Novo Nordisk Fonden
Nordea-fonden
Swiss Federal Institute of Technology Zurich
Article History
Accepted: 17 October 2024
First Online: 27 November 2024
Declarations
:
: Open access funding provided by Swiss Federal Institute of Technology Zurich.
: Andreas Clausen received travel funding during the project from Novo Nordisk and Nordea. Stefan Weiler is a member of the Human Medicine Expert Committee of Swissmedic. The views expressed in this article are the personal views of the authors and may not be understood or quoted as being made on behalf of or reflecting the position of the competent authority or one of its committees or working parties. While the authors used data from VigiBase, the World Health Organization (WHO) global database of individual case report forms, as a source of information, the conclusions do not represent the opinion of the Uppsala Monitoring Centre (UMC) or the World Health Organization. The remaining authors have no competing interests to declare.
: The study was conducted in accordance with the principles of the Declaration of Helsinki. VigiBase®, the WHO global database of individual case safety reports (ICSRs), is the source of the information; the information comes from a variety of sources, and the probability that the suspected adverse effect is drug related is not the same in all cases; the information does not represent the opinion of the Uppsala Monitoring Centre (UMC) or the World Health Organization (WHO). According to WHO policy and UMC guidelines, reports sent from the WHO Programme for International Drug Monitoring member countries to VigiBase® are anonymized. Identifiable data are not available.
: Patient consent was waived as VigiBase® database contains anonymized data that cannot allow patients’ identification.
: Not applicable.
: The authors do not have the authority to share the study data. Access to VigiBase and VigiLyze is handled directly by the Uppsala Monitoring Centre ().
: The code will be made available upon reasonable request to the corresponding author.
: Andreas Clausen: Methodology; Formal analysis; Investigation; Interpretation of results; Writing original draft; Literature review and implementation of the study. Stefan Weiler: Conceptualization; Supervision; Interpretation of results. Adrian Martinez-De la Torre: Formal analysis, Interpretation of results, Writing original revision; Methodology; Contributed to the design and implementation of the study; Interpretation of results. Andrea Burden: Methodology; Contributed to the design and implementation of the study; Interpretation of results. All authors reviewed and contributed critically to the manuscript. All authors read and approved the final version.